[Skip to Content]
[Skip to Content Landing]
Invited Commentary
Less Is More
July 23, 2012

ICDs—Increasingly Complex DecisionsComment on “Patient Preference in the Decision to Place Implantable Cardioverter-Defibrillators”

Arch Intern Med. 2012;172(14):1106-1107. doi:10.1001/archinternmed.2012.2660

The clear benefits of implantable cardioverter-defibrillators (ICDs) in selected populations have been consistently demonstrated through landmark investigations for more than 2 decades.1 After initially demonstrating efficacy in secondary prophylaxis of sudden cardiac death (SCD),2 ICDs are now first-line therapy for primary prophylaxis of SCD in many patients with ischemic or nonischemic cardiomyopathy.3,4

First Page Preview View Large
First page PDF preview
First page PDF preview